Association between an interleukin 1 receptor, type I promoter polymorphism and self-reported attentional function in women with breast cancer.
about
Cancer- and treatment-related cognitive changes: what can we do now? What lies ahead?Racial/ethnic disparities in inflammatory gene single-nucleotide polymorphisms as predictors of a high risk for symptom burden in patients with multiple myeloma 1 year after diagnosis.Co-occurrence of anxiety and depressive symptoms following breast cancer surgery and its impact on quality of lifeDifferences in demographic, clinical, and symptom characteristics and quality of life outcomes among oncology patients with different types of painAssociations of Il-1 Family-Related Polymorphisms With Gastric Cancer Risk and the Role of Mir-197 In Il-1f5 Expression.Polymorphisms in Cytokine Genes Are Associated With Higher Levels of Fatigue and Lower Levels of Energy in Women After Breast Cancer Surgery.Cytokine Gene Polymorphisms Associated With Various Domains Of Quality Of Life In Women With Breast Cancer.Characteristics associated with inter-individual differences in the trajectories of self-reported attentional function in oncology outpatients receiving chemotherapy.Inflammatory pathway genes associated with inter-individual variability in the trajectories of morning and evening fatigue in patients receiving chemotherapy.Imminent Angiotensin-converting Enzyme Inhibitor from Microbial Source for Cancer Therapy.Perceived cognitive function for breast cancer survivors: association of genetic and behaviorally related variables for inflammation.Treatment-related Decisional Conflict, Quality of Life, and Comorbidity in Older Adults with CancerDistinct attentional function profiles in older adults receiving cancer chemotherapy
P2860
Q34669341-DA58951B-E9CC-44A1-B693-A1CB0D2678DCQ35202436-9E5F54DC-D805-4A96-9727-4795464DE150Q36446745-53D22501-8F89-440A-BE2D-ACBC45CB6B6AQ37082177-D154609D-E610-429C-86A8-2A1CBFA291C4Q37328505-ECC6FC7C-03E9-4C08-90C3-162B47E385F3Q42743044-6ADCE65A-FFA0-40C1-85A7-2FE3CEB5154DQ46133827-F7F42F08-1F52-41D5-BB97-3AB89861DE71Q46432944-44264504-1C1A-45C1-AB7F-1F7C94747E40Q46893422-946F425D-C442-481C-96BF-F3361024C14DQ47139933-69ECF817-E910-42BE-91EE-BA20408D6787Q52899862-62A58B0F-E684-4CAF-9529-85C301BE6D29Q57052258-C3343047-340A-46B2-B488-77039466D489Q57486174-1E747596-3EF7-4643-AE81-E8FD2B269635
P2860
Association between an interleukin 1 receptor, type I promoter polymorphism and self-reported attentional function in women with breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association between an interle ...... n in women with breast cancer.
@en
Association between an interle ...... n in women with breast cancer.
@nl
type
label
Association between an interle ...... n in women with breast cancer.
@en
Association between an interle ...... n in women with breast cancer.
@nl
prefLabel
Association between an interle ...... n in women with breast cancer.
@en
Association between an interle ...... n in women with breast cancer.
@nl
P2093
P2860
P1433
P1476
Association between an interle ...... on in women with breast cancer
@en
P2093
Anand Dhruva
Bradley E Aouizerat
Bruce A Cooper
Charles Elboim
Christina R Baggott
Christine Miaskowski
Christine S Ritchie
Claudia West
Dale J Langford
Deborah Hamolsky
P2860
P304
P356
10.1016/J.CYTO.2013.11.003
P577
2013-12-04T00:00:00Z